Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
Clinical trial NCT00790192 · COMPLETED
Trial details
- NCT number
- NCT00790192
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2010-07-01
- Enrollment
- 488
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.